Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.

Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR.

Eur Urol. 2018 Sep 1. pii: S0302-2838(18)30605-5. doi: 10.1016/j.eururo.2018.08.020. [Epub ahead of print]

PMID:
30181067
2.

Genomic Prostate Score, PI-RADSv2, and Progression in Men with Prostate Cancer on Active Surveillance.

Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR.

J Urol. 2018 Sep 1. pii: S0022-5347(18)43795-0. doi: 10.1016/j.juro.2018.08.047. [Epub ahead of print]

PMID:
30179620
3.

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.

Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0084-3. [Epub ahead of print]

PMID:
30171230
4.

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.

Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR.

Eur Urol. 2018 Oct;74(4):444-452. doi: 10.1016/j.eururo.2018.05.014. Epub 2018 May 28.

PMID:
29853306
5.

Development of a stress response therapy targeting aggressive prostate cancer.

Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D.

Sci Transl Med. 2018 May 2;10(439). pii: eaar2036. doi: 10.1126/scitranslmed.aar2036.

PMID:
29720449
6.

Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus.

Cowan JE, Baik S, McCarthy NI, Parnell SM, White AJ, Jenkinson WE, Anderson G.

Eur J Immunol. 2018 May;48(5):844-854. doi: 10.1002/eji.201747375. Epub 2018 Jan 29.

7.

Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.

Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R.

Ann Intern Med. 2018 Jan 2;168(1):1-9. doi: 10.7326/M17-0548. Epub 2017 Nov 28.

8.

Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).

Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM.

Prostate. 2018 Jan;78(1):32-39. doi: 10.1002/pros.23441. Epub 2017 Nov 6.

PMID:
29105845
9.

Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.

Herlemann A, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2018 Feb;73(2):215-223. doi: 10.1016/j.eururo.2017.04.027. Epub 2017 May 9.

PMID:
28499617
10.

Active Surveillance in Younger Men With Prostate Cancer.

Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR.

J Clin Oncol. 2017 Jun 10;35(17):1898-1904. doi: 10.1200/JCO.2016.68.0058. Epub 2017 Mar 27.

11.

Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.

Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR.

J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22.

12.

Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.

Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR.

Eur Urol. 2017 May;71(5):750-759. doi: 10.1016/j.eururo.2016.11.032. Epub 2016 Dec 9.

PMID:
27940155
13.

A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy.

Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR.

J Urol. 2017 Feb;197(2):369-375. doi: 10.1016/j.juro.2016.08.122. Epub 2016 Sep 28.

PMID:
27693447
14.

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.

Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR.

Eur Urol. 2017 Aug;72(2):275-281. doi: 10.1016/j.eururo.2016.08.023. Epub 2016 Aug 29.

PMID:
27595378
15.

Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.

Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR.

J Urol. 2016 Sep;196(3):727-33. doi: 10.1016/j.juro.2016.03.179. Epub 2016 Apr 24.

PMID:
27117443
16.

CCR7 Controls Thymus Recirculation, but Not Production and Emigration, of Foxp3(+) T Cells.

Cowan JE, McCarthy NI, Anderson G.

Cell Rep. 2016 Feb 9;14(5):1041-1048. doi: 10.1016/j.celrep.2016.01.003. Epub 2016 Jan 28.

17.

Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development.

McCarthy NI, Cowan JE, Nakamura K, Bacon A, Baik S, White AJ, Parnell SM, Jenkinson EJ, Jenkinson WE, Anderson G.

J Immunol. 2015 Sep 15;195(6):2675-82. doi: 10.4049/jimmunol.1501226. Epub 2015 Aug 7.

18.

Natural Th17 cells are critically regulated by functional medullary thymic microenvironments.

Jenkinson WE, McCarthy NI, Dutton EE, Cowan JE, Parnell SM, White AJ, Anderson G.

J Autoimmun. 2015 Sep;63:13-22. doi: 10.1016/j.jaut.2015.06.008. Epub 2015 Jul 3.

19.

Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer.

Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR.

Eur Urol. 2015 Sep;68(3):458-63. doi: 10.1016/j.eururo.2015.06.011. Epub 2015 Jun 29.

PMID:
26138041
20.

Patterns of Local Failure following Radiation Therapy for Prostate Cancer.

Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M 3rd, Chang AJ, Chan JM, Simko JP, Carroll PR.

J Urol. 2015 Oct;194(4):977-82. doi: 10.1016/j.juro.2015.04.111. Epub 2015 May 14.

PMID:
25983194
21.

Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.

Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Sep;68(3):480-6. doi: 10.1016/j.eururo.2015.01.008. Epub 2015 Feb 2.

22.

Current Use of Imaging after Primary Treatment of Prostate Cancer.

Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR.

J Urol. 2015 Jul;194(1):98-104. doi: 10.1016/j.juro.2015.01.097. Epub 2015 Jan 30.

PMID:
25640648
23.

Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes.

Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR.

J Urol. 2015 Jul;194(1):85-90. doi: 10.1016/j.juro.2015.01.077. Epub 2015 Jan 23.

PMID:
25623742
24.

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what we learn from intrathymic migration.

Cowan JE, Jenkinson WE, Anderson G.

Eur J Immunol. 2015 Mar;45(3):652-60. doi: 10.1002/eji.201445108. Epub 2015 Feb 13. Review.

25.

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.

Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR.

J Urol. 2015 Mar;193(3):807-11. doi: 10.1016/j.juro.2014.09.094. Epub 2014 Sep 28.

26.

Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.

Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.

27.

Differential requirement for CCR4 and CCR7 during the development of innate and adaptive αβT cells in the adult thymus.

Cowan JE, McCarthy NI, Parnell SM, White AJ, Bacon A, Serge A, Irla M, Lane PJ, Jenkinson EJ, Jenkinson WE, Anderson G.

J Immunol. 2014 Aug 1;193(3):1204-12. doi: 10.4049/jimmunol.1400993. Epub 2014 Jul 2.

28.

Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy.

Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR.

J Robot Surg. 2014 Jun;8(2):99-104. doi: 10.1007/s11701-013-0432-1. Epub 2013 Aug 15.

PMID:
27637518
29.

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR.

Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004. Epub 2014 May 16.

30.

Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.

Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Mar;67(3):451-7. doi: 10.1016/j.eururo.2014.03.026. Epub 2014 Apr 5.

31.

Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.

Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR.

BJU Int. 2014 Dec;114(6b):E18-E24. doi: 10.1111/bju.12554. Epub 2014 Feb 20.

32.

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW.

Prostate Cancer Prostatic Dis. 2014 Jun;17(2):174-9. doi: 10.1038/pcan.2014.5. Epub 2014 Mar 11.

PMID:
24614692
33.

Age and baseline quality of life at radical prostatectomy--who has the most to lose?

Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR.

J Urol. 2014 Aug;192(2):396-401. doi: 10.1016/j.juro.2014.02.045. Epub 2014 Feb 25.

PMID:
24582539
34.

An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells.

White AJ, Jenkinson WE, Cowan JE, Parnell SM, Bacon A, Jones ND, Jenkinson EJ, Anderson G.

J Immunol. 2014 Mar 15;192(6):2659-66. doi: 10.4049/jimmunol.1303057. Epub 2014 Feb 7.

35.

Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort.

Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR.

Urology. 2014 Jan;83(1):33-8. doi: 10.1016/j.urology.2013.05.070. Epub 2013 Nov 15.

PMID:
24246319
36.

Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.

Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR.

J Urol. 2014 Apr;191(4):964-70. doi: 10.1016/j.juro.2013.10.098. Epub 2013 Oct 29.

37.

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.

Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR.

Eur Urol. 2014 Aug;66(2):337-42. doi: 10.1016/j.eururo.2013.08.060. Epub 2013 Sep 9.

PMID:
24035632
38.

Reply to A. Azad et al.

Cooperberg MR, Cowan JE, Carroll PR.

J Clin Oncol. 2013 Sep 10;31(26):3296-7. doi: 10.1200/JCO.2013.51.4919. Epub 2013 Aug 12. No abstract available.

39.

A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.

Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR.

BJU Int. 2013 Jul;112(2):E67-75. doi: 10.1111/bju.12209.

40.

Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.

Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL.

Urology. 2013 Jul;82(1):60-5. doi: 10.1016/j.urology.2013.01.072. Epub 2013 May 21.

41.

Mechanisms of thymus medulla development and function.

Anderson G, Baik S, Cowan JE, Holland AM, McCarthy NI, Nakamura K, Parnell SM, White AJ, Lane PJ, Jenkinson EJ, Jenkinson WE.

Curr Top Microbiol Immunol. 2014;373:19-47. doi: 10.1007/82_2013_320. Review.

PMID:
23612988
42.

The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development.

Cowan JE, Parnell SM, Nakamura K, Caamano JH, Lane PJ, Jenkinson EJ, Jenkinson WE, Anderson G.

J Exp Med. 2013 Apr 8;210(4):675-81. doi: 10.1084/jem.20122070. Epub 2013 Mar 25.

43.

Benign prostate glandular tissue at radical prostatectomy surgical margins.

Odisho AY, Washington SL 3rd, Meng MV, Cowan JE, Simko JP, Carroll PR.

Urology. 2013 Jul;82(1):154-9. doi: 10.1016/j.urology.2012.12.063. Epub 2013 Mar 21.

44.

Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort.

Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR.

J Clin Oncol. 2013 Apr 10;31(11):1428-34. doi: 10.1200/JCO.2012.46.4396. Epub 2013 Mar 4.

45.

How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?

Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR.

BJU Int. 2013 Aug;112(4):E314-20. doi: 10.1111/j.1464-410X.2012.11493.x. Epub 2013 Mar 4.

46.

Active surveillance: does serial prostate biopsy increase histological inflammation?

Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR.

Prostate Cancer Prostatic Dis. 2013 Jun;16(2):165-9. doi: 10.1038/pcan.2012.51. Epub 2013 Jan 15.

PMID:
23318528
47.

A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.

Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD.

Adv Anat Pathol. 2013 Jan;20(1):39-44. doi: 10.1097/PAP.0b013e31827b665b. Review.

48.

Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla.

Desanti GE, Cowan JE, Baik S, Parnell SM, White AJ, Penninger JM, Lane PJ, Jenkinson EJ, Jenkinson WE, Anderson G.

J Immunol. 2012 Dec 15;189(12):5519-26. doi: 10.4049/jimmunol.1201815. Epub 2012 Nov 14.

49.

Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF.

BJU Int. 2013 Feb;111(2):213-20. doi: 10.1111/j.1464-410X.2012.11423.x. Epub 2012 Aug 29.

50.

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.

Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL.

J Clin Oncol. 2012 Oct 1;30(28):3540-4. Epub 2012 Aug 27.

Supplemental Content

Loading ...
Support Center